close read more

NEWSROOM

Servier collaborates with Harvard researchers to fight metabolic diseases

21 / 03 / 2019Press release

Parkinson’s disease: Servier and Oncodesign join forces to investigate new line of research

11 / 03 / 2019Press release

WeHealth by Servier and CureMatch announce partnership to deliver a decision-support digital platform for oncologists worldwide

04 / 03 / 2019Press release

WeHealth by Servier and the Massachusetts Institute of Technology form collaboration to facilitate the emergence of connected homecare

13 / 02 / 2019Press release

Servier: 2017-2018 Financial Figures

31 / 01 / 2019Press release

Servier and Iktos announce their successful collaboration in the field of artificial intelligence

29 / 01 / 2019Press release

The FDA has cleared an investigational new drug application for an allogeneic CAR T therapy

28 / 01 / 2019Press release

Servier celebrates 60 years of its establishment in Spain

14 / 12 / 2018Press release

Kurma Partners announces the first closing of 
Kurma Biofund III

14 / 12 / 2018Press release

Servier joins Embleema’s Blockchain Health Consortium to launch a pilot project for Blockchain

04 / 12 / 2018Press release

Servier and Allogene Therapeutics present pooled data from Phase 1 Trials of Allogeneic UCART19 in Relapsed/Refractory Acute Lymphoblastic Leukemia

04 / 12 / 2018Press release

Mécénat Servier celebrates its second anniversary

28 / 11 / 2018Press release